Transdermal nitroglycerin delivery using acrylic matrices: design, formulation, and in vitro characterization
Houman Savoji1, Amir Mehdizadeh2, Ahmad Ramazani Saadat Abadi3
1Chemical and Petroleum Engineering Department, Sharif University of Technology, Azadi Avenue, Tehran 11365 8639, Iran ; Hakim Pharmaceutical Co., 1370 Dr. Shariati Avenue, Gholhak, Tehran 11155 4465, Iran.
Abstract:
Nitroglycerin (TNG) transdermal drug delivery systems (TDDSs) with different acrylic pressure-sensitive adhesives (PSAs) and chemical permeation enhancers (CPEs) were prepared. The effects of PSAs and CPEs types and concentrations on skin permeation and in vitro drug release from devices were evaluated using the dissolution method as well as the modified-jacketed Franz diffusion cells fitted with excised rat abdominal skin. It was demonstrated that the permeation rate or steady state flux (J ss) of the drug through the excised rat skin was dependent on the viscosity and type of acrylic PSA as well as the type of CPE. Among different acrylic PSAs, Duro-Tak 2516 and Duro-Tak 2054 showed the highest and Duro-Tak 2051 showed the lowest J ss. Among the various CPEs, propylene glycol and cetyl alcohol showed the highest and the lowest enhancement of the skin permeation of TNG, respectively. The adhesion properties of devices such as 180° peel strength and probe tack values were obtained. It was shown that increasing the concentration of CPE led to reduction in the adhesion property of PSA. Moreover, after optimization of the formulation, it was found that the use of 10% PG as a CPE and 25% nitroglycerin loading in Duro-Tak 2054 is an effective monolithic DIAP for the development of a transdermal therapeutic system for nitroglycerin.
More Related Videos
12:22Synthesis of Thermogelling PolyN-isopropylacrylamide-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering
Published on: October 26, 2016
11:32Fabrication of Biologically Derived Injectable Materials for Myocardial Tissue Engineering
Published on: December 20, 2010
Related Concept Videos
Drug Delivery: Enteral Route
Transdermal Drug Delivery Systems
Intrauterine Drug Delivery Systems
Modified-Release Drug Delivery Systems: Rate-Programmed II
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Modified-Release Drug Delivery Systems: Influencing Factors
